Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia – Impact on enzyme activity and response to cytotoxics

The triphenylethylene antiestrogen, tamoxifen, can be an effective inhibitor of sphingolipid metabolism. This off-target activity makes tamoxifen an interesting ancillary for boosting the apoptosis-inducing properties of ceramide, a sphingolipid with valuable tumor censoring activity. Here we show f...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Biochim Biophys Acta
Hoofdauteurs: Morad, Samy A. F., Tan, Su-Fern, Feith, David J., Kester, Mark, Claxton, David F., Loughran, Thomas P., Barth, Brian M., Fox, Todd E., Cabot, Myles C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459585/
https://ncbi.nlm.nih.gov/pubmed/25769964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2015.03.001
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items